Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF
- 1 March 2011
- Vol. 29 (11) , 2131-2139
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectorsExpert Opinion on Biological Therapy, 2009
- Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectorsVaccine, 2009
- New Insights on Adenovirus as Vaccine VectorsMolecular Therapy, 2009
- Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in MicePLOS ONE, 2008
- Protective Immunity toPseudomonas aeruginosaInduced with a Capsid-Modified Adenovirus ExpressingP. aeruginosaOprFJournal of Virology, 2007
- New Pre-pandemic Influenza Vaccines: An Egg- and Adjuvant-independent Human Adenoviral Vector Strategy Induces Long-lasting Protective Immune Responses in MiceClinical Pharmacology & Therapeutics, 2007
- Chimpanzee Adenovirus Antibodies in Humans, Sub-Saharan AfricaEmerging Infectious Diseases, 2006
- Immunological insights from genetic vaccinesVirus Research, 2005
- Characterization of a Family of Chimpanzee Adenoviruses and Development of Molecular Clones for Gene Transfer VectorsHuman Gene Therapy, 2004
- Comparison of two immunization schedules for a Pseudomonas aeruginosa outer membrane proteins vaccine in burn patientsVaccine, 2000